186 related articles for article (PubMed ID: 18925912)
1. Anti-VEGF therapy: riding the wave of change.
Hunyor AP
Clin Exp Ophthalmol; 2008 Jul; 36(5):401-2. PubMed ID: 18925912
[No Abstract] [Full Text] [Related]
2. Correspondence.
Uparkar M; Maiti A; Natarajan S
Retina; 2008 Mar; 28(3):527; author reply 527-8. PubMed ID: 18327151
[No Abstract] [Full Text] [Related]
3. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
Spandau UH; Jonas JB
Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
[No Abstract] [Full Text] [Related]
4. Comparing ranibizumab with bevacizumab.
Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
[No Abstract] [Full Text] [Related]
5. Necessity of paracentesis before or after intravitreal injection of bevacizumab.
Huang WC; Lin JM; Chiang CC; Tsai YY
Arch Ophthalmol; 2008 Sep; 126(9):1314-5; author reply 1315. PubMed ID: 18779502
[No Abstract] [Full Text] [Related]
6. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Bom Aggio F; Eid Farah M; Melo GB
Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
[No Abstract] [Full Text] [Related]
7. Intravitreal avastin: the low cost alternative to lucentis?
Rosenfeld PJ
Am J Ophthalmol; 2006 Jul; 142(1):141-3. PubMed ID: 16815262
[No Abstract] [Full Text] [Related]
8. Controversies in the treatment of wet age-related macular degeneration.
Moreno SF; Paloma JB
Am J Ophthalmol; 2008 May; 145(5):937; author reply 938. PubMed ID: 18435977
[No Abstract] [Full Text] [Related]
9. Paracentesis before intravitreal injection of bevacizumab.
Tsui YP; Chiang CC; Tsai YY
Can J Ophthalmol; 2008 Apr; 43(2):239; author reply 239-40. PubMed ID: 18347632
[No Abstract] [Full Text] [Related]
10. Intravitreal bevacizumab.
Lucas RS; McKee HD; Lee LR
Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
[No Abstract] [Full Text] [Related]
11. The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system.
Spaide RF
Am J Ophthalmol; 2009 Jul; 148(1):1-3. PubMed ID: 19540983
[No Abstract] [Full Text] [Related]
12. Antivascular endothelial growth factors in age-related macular degeneration.
Schmidt-Erfurth U; Pollreisz A; Mitsch C; Bolz M
Dev Ophthalmol; 2010; 46():21-38. PubMed ID: 20703030
[TBL] [Abstract][Full Text] [Related]
13. Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degeneration.
Chang TS; Kokame G; Casey R; Prenner J; Feiner L; Anderson N
Retina; 2009 Oct; 29(9):1235-41. PubMed ID: 19934818
[TBL] [Abstract][Full Text] [Related]
14. Ranibizumab and stroke.
Ueta T; Yanagi Y; Tamaki Y; Yamaguchi T
Ophthalmology; 2010 Sep; 117(9):1860; author reply 1860-1. PubMed ID: 20816253
[No Abstract] [Full Text] [Related]
15. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
Chan WM; Lai TY; Chan KP; Li H; Liu DT; Lam DS; Pang CP
Retina; 2008 Oct; 28(9):1308-13. PubMed ID: 18728623
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.
Jonas JB; Tao Y; Rensch F
Acta Ophthalmol; 2011 Feb; 89(1):e105-7. PubMed ID: 20064119
[No Abstract] [Full Text] [Related]
17. Ranibizumab and nonocular hemorrhage.
Beaumont PE; Kang HK
Ophthalmology; 2009 Aug; 116(8):1593. PubMed ID: 19651322
[No Abstract] [Full Text] [Related]
18. Erratum: Ranibizumab and Nonocular Hemorrhage.
Beaumont PE; Kang HK
Ophthalmology; 2010 Aug; 117(8):1662-3; author reply 1663-4. PubMed ID: 20712066
[No Abstract] [Full Text] [Related]
19. Case of anterior uveitis after intravitreal injection of bevacizumab.
Pieramici DJ; Avery RL; Castellarin AA; Nasir MA; Rabena M
Retina; 2006 Sep; 26(7):841-2. PubMed ID: 16963867
[No Abstract] [Full Text] [Related]
20. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
You JY; Chung H; Kim HC
Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]